Uncontrolled Hypertension vs.Resistant Hypertension: Prevalence, Prognosis, and Treatment - Michael Weber, MD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Hypertension Definition, Pathophysiology, New Targets and Medical Therapy

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Uncontrolled Hypertension vs.Resistant Hypertension: Prevalence, Prognosis, and Treatment presented by Michael Weber, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Resistant Hypertension

Session Name: Hypertension Definition, Pathophysiology, New Targets and Medical Therapy

Track: Technology & Innovation

Learning Objectives

  • Updates in Renal Denervation and Hypertension Therapies 

Other Components in this Moment

Overview
Uncontrolled Hypertension vs.Resistant Hypertension: Prevalence, Prognosis, and Treatment - Michael Weber, MD
New Targets for Optimal Blood Pressure after SPRINT - Michael Weber, MD
Impact of Baseline Blood Pressure and Age on Controlling Blood Pressure - Brent, Egan, MD
Loading Simple Education